title: Skin lesions as another possible clinical manifestation of mitochondrial toxicity in an HIV-infected patient.
authors.forename: C
authors.initials: C
authors.lastname: Bachmeyer
authors.forename: V
authors.initials: V
authors.lastname: Orlandini
authors.forename: D
authors.initials: D
authors.lastname: Grimaldi
authors.forename: P
authors.initials: P
authors.lastname: Bonnard
authors.forename: P
authors.initials: P
authors.lastname: Moguelet
authors.forename: S
authors.initials: S
authors.lastname: Aractingi
mesh_terms: D015658:HIV Infections / Q000188:drug therapy*; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D008875:Middle Aged; D028361:Mitochondrial Diseases / Q000139:chemically induced* / Q000150:complications*; D009705:Nucleosides; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000209:etiology* / Q000473:pathology*
chemical_list: D009705:Nucleosides; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase